Secukinumab 300 MG; Tofacitinib 11mg
2024-0358
Unknown small_molecule active
Quick answer
Secukinumab 300 MG; Tofacitinib 11mg for Hidradenitis Suppurativa is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Hidradenitis Suppurativa
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active